nodes	percent_of_prediction	percent_of_DWPC	metapath
Dactinomycin—ABCC1—Methotrexate—psoriatic arthritis	0.147	0.187	CbGbCtD
Dactinomycin—ABCG2—Dexamethasone—psoriatic arthritis	0.122	0.156	CbGbCtD
Dactinomycin—ABCB1—Methylprednisolone—psoriatic arthritis	0.117	0.149	CbGbCtD
Dactinomycin—ABCG2—Methotrexate—psoriatic arthritis	0.0984	0.125	CbGbCtD
Dactinomycin—ABCB1—Betamethasone—psoriatic arthritis	0.0759	0.0966	CbGbCtD
Dactinomycin—ABCB1—Prednisolone—psoriatic arthritis	0.0749	0.0953	CbGbCtD
Dactinomycin—ABCB1—Prednisone—psoriatic arthritis	0.0707	0.09	CbGbCtD
Dactinomycin—ABCB1—Dexamethasone—psoriatic arthritis	0.0442	0.0562	CbGbCtD
Dactinomycin—ABCB1—Methotrexate—psoriatic arthritis	0.0355	0.0452	CbGbCtD
Dactinomycin—Growth retardation—Methylprednisolone—psoriatic arthritis	0.00725	0.0338	CcSEcCtD
Dactinomycin—Growth retardation—Dexamethasone—psoriatic arthritis	0.00659	0.0308	CcSEcCtD
Dactinomycin—Growth retardation—Betamethasone—psoriatic arthritis	0.00659	0.0308	CcSEcCtD
Dactinomycin—Growth retardation—Prednisone—psoriatic arthritis	0.00574	0.0268	CcSEcCtD
Dactinomycin—Aplastic anaemia—Auranofin—psoriatic arthritis	0.00528	0.0247	CcSEcCtD
Dactinomycin—Dysphagia—Auranofin—psoriatic arthritis	0.00353	0.0165	CcSEcCtD
Dactinomycin—Pancytopenia—Auranofin—psoriatic arthritis	0.00335	0.0156	CcSEcCtD
Dactinomycin—Neutropenia—Auranofin—psoriatic arthritis	0.0033	0.0154	CcSEcCtD
Dactinomycin—Stomatitis—Auranofin—psoriatic arthritis	0.00307	0.0143	CcSEcCtD
Dactinomycin—Agranulocytosis—Auranofin—psoriatic arthritis	0.00294	0.0137	CcSEcCtD
Dactinomycin—Folliculitis—Triamcinolone—psoriatic arthritis	0.00262	0.0122	CcSEcCtD
Dactinomycin—Folliculitis—Methylprednisolone—psoriatic arthritis	0.00262	0.0122	CcSEcCtD
Dactinomycin—Hepatomegaly—Prednisolone—psoriatic arthritis	0.00253	0.0118	CcSEcCtD
Dactinomycin—Alopecia—Auranofin—psoriatic arthritis	0.0025	0.0117	CcSEcCtD
Dactinomycin—Folliculitis—Betamethasone—psoriatic arthritis	0.00238	0.0111	CcSEcCtD
Dactinomycin—Folliculitis—Dexamethasone—psoriatic arthritis	0.00238	0.0111	CcSEcCtD
Dactinomycin—Ulcerative stomatitis—Methotrexate—psoriatic arthritis	0.00236	0.011	CcSEcCtD
Dactinomycin—Raised liver function tests—Methotrexate—psoriatic arthritis	0.00236	0.011	CcSEcCtD
Dactinomycin—Hepatomegaly—Triamcinolone—psoriatic arthritis	0.00233	0.0109	CcSEcCtD
Dactinomycin—Hepatomegaly—Methylprednisolone—psoriatic arthritis	0.00232	0.0109	CcSEcCtD
Dactinomycin—Anaemia—Auranofin—psoriatic arthritis	0.00227	0.0106	CcSEcCtD
Dactinomycin—Leukopenia—Auranofin—psoriatic arthritis	0.0022	0.0103	CcSEcCtD
Dactinomycin—Febrile neutropenia—Prednisone—psoriatic arthritis	0.00217	0.0101	CcSEcCtD
Dactinomycin—Hepatomegaly—Dexamethasone—psoriatic arthritis	0.00211	0.00987	CcSEcCtD
Dactinomycin—Hepatomegaly—Betamethasone—psoriatic arthritis	0.00211	0.00987	CcSEcCtD
Dactinomycin—Necrosis—Methylprednisolone—psoriatic arthritis	0.0021	0.00979	CcSEcCtD
Dactinomycin—Thrombocytopenia—Auranofin—psoriatic arthritis	0.00196	0.00917	CcSEcCtD
Dactinomycin—Anorexia—Auranofin—psoriatic arthritis	0.00191	0.00893	CcSEcCtD
Dactinomycin—Necrosis—Betamethasone—psoriatic arthritis	0.00191	0.0089	CcSEcCtD
Dactinomycin—Necrosis—Dexamethasone—psoriatic arthritis	0.00191	0.0089	CcSEcCtD
Dactinomycin—Hepatomegaly—Prednisone—psoriatic arthritis	0.00184	0.0086	CcSEcCtD
Dactinomycin—Febrile neutropenia—Methotrexate—psoriatic arthritis	0.00181	0.00845	CcSEcCtD
Dactinomycin—Eruption—Methotrexate—psoriatic arthritis	0.00177	0.00827	CcSEcCtD
Dactinomycin—Decreased appetite—Auranofin—psoriatic arthritis	0.00174	0.00814	CcSEcCtD
Dactinomycin—Ulcer—Triamcinolone—psoriatic arthritis	0.00174	0.00814	CcSEcCtD
Dactinomycin—Folliculitis—Methotrexate—psoriatic arthritis	0.00173	0.00809	CcSEcCtD
Dactinomycin—Extravasation—Dexamethasone—psoriatic arthritis	0.00171	0.00801	CcSEcCtD
Dactinomycin—Extravasation—Betamethasone—psoriatic arthritis	0.00171	0.00801	CcSEcCtD
Dactinomycin—Necrosis—Prednisone—psoriatic arthritis	0.00166	0.00775	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00164	0.00766	CcSEcCtD
Dactinomycin—Abdominal pain—Auranofin—psoriatic arthritis	0.00159	0.00741	CcSEcCtD
Dactinomycin—Ulcer—Dexamethasone—psoriatic arthritis	0.00158	0.00739	CcSEcCtD
Dactinomycin—Ulcer—Betamethasone—psoriatic arthritis	0.00158	0.00739	CcSEcCtD
Dactinomycin—Oesophagitis—Methylprednisolone—psoriatic arthritis	0.0015	0.00702	CcSEcCtD
Dactinomycin—Hepatotoxicity—Methotrexate—psoriatic arthritis	0.00141	0.00658	CcSEcCtD
Dactinomycin—Necrosis—Methotrexate—psoriatic arthritis	0.00139	0.00648	CcSEcCtD
Dactinomycin—Ulcer—Prednisone—psoriatic arthritis	0.00138	0.00643	CcSEcCtD
Dactinomycin—Diarrhoea—Auranofin—psoriatic arthritis	0.00137	0.00641	CcSEcCtD
Dactinomycin—Oesophagitis—Dexamethasone—psoriatic arthritis	0.00137	0.00638	CcSEcCtD
Dactinomycin—Oesophagitis—Betamethasone—psoriatic arthritis	0.00137	0.00638	CcSEcCtD
Dactinomycin—Vomiting—Auranofin—psoriatic arthritis	0.00128	0.00596	CcSEcCtD
Dactinomycin—Rash—Auranofin—psoriatic arthritis	0.00126	0.00591	CcSEcCtD
Dactinomycin—Extravasation—Methotrexate—psoriatic arthritis	0.00125	0.00583	CcSEcCtD
Dactinomycin—Nausea—Auranofin—psoriatic arthritis	0.00119	0.00556	CcSEcCtD
Dactinomycin—Oesophagitis—Prednisone—psoriatic arthritis	0.00119	0.00556	CcSEcCtD
Dactinomycin—Ulcer—Methotrexate—psoriatic arthritis	0.00115	0.00538	CcSEcCtD
Dactinomycin—Sepsis—Prednisone—psoriatic arthritis	0.00113	0.00528	CcSEcCtD
Dactinomycin—Lethargy—Betamethasone—psoriatic arthritis	0.00111	0.00517	CcSEcCtD
Dactinomycin—Lethargy—Dexamethasone—psoriatic arthritis	0.00111	0.00517	CcSEcCtD
Dactinomycin—Aplastic anaemia—Methotrexate—psoriatic arthritis	0.00102	0.00477	CcSEcCtD
Dactinomycin—Mouth ulceration—Methotrexate—psoriatic arthritis	0.000984	0.0046	CcSEcCtD
Dactinomycin—Lethargy—Prednisone—psoriatic arthritis	0.000965	0.00451	CcSEcCtD
Dactinomycin—Sepsis—Methotrexate—psoriatic arthritis	0.000945	0.00441	CcSEcCtD
Dactinomycin—Hepatic failure—Methotrexate—psoriatic arthritis	0.00088	0.00411	CcSEcCtD
Dactinomycin—Pharyngitis—Triamcinolone—psoriatic arthritis	0.000822	0.00384	CcSEcCtD
Dactinomycin—Lethargy—Methotrexate—psoriatic arthritis	0.000807	0.00377	CcSEcCtD
Dactinomycin—Erythema—Prednisolone—psoriatic arthritis	0.000784	0.00366	CcSEcCtD
Dactinomycin—Neutropenia—Prednisone—psoriatic arthritis	0.000764	0.00357	CcSEcCtD
Dactinomycin—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.00073	0.00341	CcSEcCtD
Dactinomycin—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.000727	0.0034	CcSEcCtD
Dactinomycin—Erythema—Triamcinolone—psoriatic arthritis	0.000721	0.00337	CcSEcCtD
Dactinomycin—Erythema—Methylprednisolone—psoriatic arthritis	0.000719	0.00336	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.000712	0.00332	CcSEcCtD
Dactinomycin—Malaise—Prednisolone—psoriatic arthritis	0.000707	0.0033	CcSEcCtD
Dactinomycin—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000669	0.00312	CcSEcCtD
Dactinomycin—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000667	0.00312	CcSEcCtD
Dactinomycin—Alopecia—Betamethasone—psoriatic arthritis	0.000664	0.0031	CcSEcCtD
Dactinomycin—Alopecia—Dexamethasone—psoriatic arthritis	0.000664	0.0031	CcSEcCtD
Dactinomycin—Discomfort—Prednisolone—psoriatic arthritis	0.000659	0.00308	CcSEcCtD
Dactinomycin—Erythema—Dexamethasone—psoriatic arthritis	0.000654	0.00305	CcSEcCtD
Dactinomycin—Erythema—Betamethasone—psoriatic arthritis	0.000654	0.00305	CcSEcCtD
Dactinomycin—Malaise—Triamcinolone—psoriatic arthritis	0.00065	0.00304	CcSEcCtD
Dactinomycin—Pancytopenia—Methotrexate—psoriatic arthritis	0.000649	0.00303	CcSEcCtD
Dactinomycin—Malaise—Methylprednisolone—psoriatic arthritis	0.000649	0.00303	CcSEcCtD
Dactinomycin—Oedema—Prednisolone—psoriatic arthritis	0.00064	0.00299	CcSEcCtD
Dactinomycin—Neutropenia—Methotrexate—psoriatic arthritis	0.000639	0.00298	CcSEcCtD
Dactinomycin—Myalgia—Triamcinolone—psoriatic arthritis	0.000614	0.00287	CcSEcCtD
Dactinomycin—Pneumonia—Methotrexate—psoriatic arthritis	0.000613	0.00286	CcSEcCtD
Dactinomycin—Myalgia—Methylprednisolone—psoriatic arthritis	0.000612	0.00286	CcSEcCtD
Dactinomycin—Flushing—Prednisone—psoriatic arthritis	0.000607	0.00284	CcSEcCtD
Dactinomycin—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000607	0.00283	CcSEcCtD
Dactinomycin—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000607	0.00283	CcSEcCtD
Dactinomycin—Discomfort—Triamcinolone—psoriatic arthritis	0.000606	0.00283	CcSEcCtD
Dactinomycin—Discomfort—Methylprednisolone—psoriatic arthritis	0.000605	0.00282	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000604	0.00282	CcSEcCtD
Dactinomycin—Stomatitis—Methotrexate—psoriatic arthritis	0.000594	0.00277	CcSEcCtD
Dactinomycin—Malaise—Dexamethasone—psoriatic arthritis	0.00059	0.00275	CcSEcCtD
Dactinomycin—Malaise—Betamethasone—psoriatic arthritis	0.00059	0.00275	CcSEcCtD
Dactinomycin—Oedema—Triamcinolone—psoriatic arthritis	0.000588	0.00275	CcSEcCtD
Dactinomycin—Infection—Triamcinolone—psoriatic arthritis	0.000584	0.00273	CcSEcCtD
Dactinomycin—Infection—Methylprednisolone—psoriatic arthritis	0.000583	0.00272	CcSEcCtD
Dactinomycin—Alopecia—Prednisone—psoriatic arthritis	0.000578	0.0027	CcSEcCtD
Dactinomycin—Erythema—Prednisone—psoriatic arthritis	0.00057	0.00266	CcSEcCtD
Dactinomycin—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000568	0.00265	CcSEcCtD
Dactinomycin—Myalgia—Dexamethasone—psoriatic arthritis	0.000557	0.0026	CcSEcCtD
Dactinomycin—Myalgia—Betamethasone—psoriatic arthritis	0.000557	0.0026	CcSEcCtD
Dactinomycin—Discomfort—Dexamethasone—psoriatic arthritis	0.00055	0.00257	CcSEcCtD
Dactinomycin—Discomfort—Betamethasone—psoriatic arthritis	0.00055	0.00257	CcSEcCtD
Dactinomycin—Pain—Prednisolone—psoriatic arthritis	0.000547	0.00255	CcSEcCtD
Dactinomycin—Hepatitis—Methotrexate—psoriatic arthritis	0.000547	0.00255	CcSEcCtD
Dactinomycin—Pharyngitis—Methotrexate—psoriatic arthritis	0.000543	0.00253	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000536	0.0025	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000535	0.0025	CcSEcCtD
Dactinomycin—Oedema—Betamethasone—psoriatic arthritis	0.000534	0.00249	CcSEcCtD
Dactinomycin—Oedema—Dexamethasone—psoriatic arthritis	0.000534	0.00249	CcSEcCtD
Dactinomycin—Infection—Betamethasone—psoriatic arthritis	0.00053	0.00248	CcSEcCtD
Dactinomycin—Infection—Dexamethasone—psoriatic arthritis	0.00053	0.00248	CcSEcCtD
Dactinomycin—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000528	0.00247	CcSEcCtD
Dactinomycin—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000527	0.00246	CcSEcCtD
Dactinomycin—Anaemia—Prednisone—psoriatic arthritis	0.000526	0.00246	CcSEcCtD
Dactinomycin—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000523	0.00244	CcSEcCtD
Dactinomycin—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000523	0.00244	CcSEcCtD
Dactinomycin—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000517	0.00241	CcSEcCtD
Dactinomycin—Malaise—Prednisone—psoriatic arthritis	0.000514	0.0024	CcSEcCtD
Dactinomycin—Anorexia—Betamethasone—psoriatic arthritis	0.000509	0.00238	CcSEcCtD
Dactinomycin—Anorexia—Dexamethasone—psoriatic arthritis	0.000509	0.00238	CcSEcCtD
Dactinomycin—Fatigue—Triamcinolone—psoriatic arthritis	0.000507	0.00237	CcSEcCtD
Dactinomycin—Fatigue—Methylprednisolone—psoriatic arthritis	0.000506	0.00236	CcSEcCtD
Dactinomycin—Pain—Triamcinolone—psoriatic arthritis	0.000503	0.00235	CcSEcCtD
Dactinomycin—Chills—Methotrexate—psoriatic arthritis	0.000491	0.00229	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000486	0.00227	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000486	0.00227	CcSEcCtD
Dactinomycin—Myalgia—Prednisone—psoriatic arthritis	0.000485	0.00226	CcSEcCtD
Dactinomycin—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000485	0.00226	CcSEcCtD
Dactinomycin—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000484	0.00226	CcSEcCtD
Dactinomycin—Alopecia—Methotrexate—psoriatic arthritis	0.000483	0.00226	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00048	0.00224	CcSEcCtD
Dactinomycin—Discomfort—Prednisone—psoriatic arthritis	0.000479	0.00224	CcSEcCtD
Dactinomycin—Erythema—Methotrexate—psoriatic arthritis	0.000476	0.00222	CcSEcCtD
Dactinomycin—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000471	0.0022	CcSEcCtD
Dactinomycin—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000465	0.00217	CcSEcCtD
Dactinomycin—Oedema—Prednisone—psoriatic arthritis	0.000465	0.00217	CcSEcCtD
Dactinomycin—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000464	0.00217	CcSEcCtD
Dactinomycin—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000464	0.00217	CcSEcCtD
Dactinomycin—Decreased appetite—Betamethasone—psoriatic arthritis	0.000464	0.00217	CcSEcCtD
Dactinomycin—Infection—Prednisone—psoriatic arthritis	0.000462	0.00216	CcSEcCtD
Dactinomycin—Fatigue—Betamethasone—psoriatic arthritis	0.00046	0.00215	CcSEcCtD
Dactinomycin—Fatigue—Dexamethasone—psoriatic arthritis	0.00046	0.00215	CcSEcCtD
Dactinomycin—Pain—Dexamethasone—psoriatic arthritis	0.000456	0.00213	CcSEcCtD
Dactinomycin—Pain—Betamethasone—psoriatic arthritis	0.000456	0.00213	CcSEcCtD
Dactinomycin—Anorexia—Prednisone—psoriatic arthritis	0.000443	0.00207	CcSEcCtD
Dactinomycin—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000442	0.00206	CcSEcCtD
Dactinomycin—Anaemia—Methotrexate—psoriatic arthritis	0.00044	0.00205	CcSEcCtD
Dactinomycin—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00044	0.00205	CcSEcCtD
Dactinomycin—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00044	0.00205	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000436	0.00204	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000436	0.00204	CcSEcCtD
Dactinomycin—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000433	0.00202	CcSEcCtD
Dactinomycin—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000432	0.00202	CcSEcCtD
Dactinomycin—Malaise—Methotrexate—psoriatic arthritis	0.000429	0.002	CcSEcCtD
Dactinomycin—Leukopenia—Methotrexate—psoriatic arthritis	0.000426	0.00199	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000423	0.00198	CcSEcCtD
Dactinomycin—Asthenia—Triamcinolone—psoriatic arthritis	0.000422	0.00197	CcSEcCtD
Dactinomycin—Abdominal pain—Betamethasone—psoriatic arthritis	0.000422	0.00197	CcSEcCtD
Dactinomycin—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000422	0.00197	CcSEcCtD
Dactinomycin—Body temperature increased—Betamethasone—psoriatic arthritis	0.000422	0.00197	CcSEcCtD
Dactinomycin—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000422	0.00197	CcSEcCtD
Dactinomycin—Asthenia—Methylprednisolone—psoriatic arthritis	0.000421	0.00197	CcSEcCtD
Dactinomycin—Myalgia—Methotrexate—psoriatic arthritis	0.000405	0.00189	CcSEcCtD
Dactinomycin—Decreased appetite—Prednisone—psoriatic arthritis	0.000404	0.00189	CcSEcCtD
Dactinomycin—Rash—Prednisolone—psoriatic arthritis	0.000403	0.00188	CcSEcCtD
Dactinomycin—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000402	0.00188	CcSEcCtD
Dactinomycin—Fatigue—Prednisone—psoriatic arthritis	0.000401	0.00187	CcSEcCtD
Dactinomycin—Discomfort—Methotrexate—psoriatic arthritis	0.0004	0.00187	CcSEcCtD
Dactinomycin—Infection—Methotrexate—psoriatic arthritis	0.000386	0.0018	CcSEcCtD
Dactinomycin—Feeling abnormal—Prednisone—psoriatic arthritis	0.000383	0.00179	CcSEcCtD
Dactinomycin—Asthenia—Dexamethasone—psoriatic arthritis	0.000383	0.00179	CcSEcCtD
Dactinomycin—Asthenia—Betamethasone—psoriatic arthritis	0.000383	0.00179	CcSEcCtD
Dactinomycin—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00038	0.00178	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00038	0.00177	CcSEcCtD
Dactinomycin—Nausea—Prednisolone—psoriatic arthritis	0.00038	0.00177	CcSEcCtD
Dactinomycin—Vomiting—Triamcinolone—psoriatic arthritis	0.000374	0.00175	CcSEcCtD
Dactinomycin—Vomiting—Methylprednisolone—psoriatic arthritis	0.000373	0.00174	CcSEcCtD
Dactinomycin—Rash—Triamcinolone—psoriatic arthritis	0.000371	0.00173	CcSEcCtD
Dactinomycin—Anorexia—Methotrexate—psoriatic arthritis	0.00037	0.00173	CcSEcCtD
Dactinomycin—Rash—Methylprednisolone—psoriatic arthritis	0.00037	0.00173	CcSEcCtD
Dactinomycin—Body temperature increased—Prednisone—psoriatic arthritis	0.000367	0.00172	CcSEcCtD
Dactinomycin—Abdominal pain—Prednisone—psoriatic arthritis	0.000367	0.00172	CcSEcCtD
Dactinomycin—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000365	0.00171	CcSEcCtD
Dactinomycin—Diarrhoea—Betamethasone—psoriatic arthritis	0.000365	0.00171	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000354	0.00165	CcSEcCtD
Dactinomycin—Nausea—Triamcinolone—psoriatic arthritis	0.000349	0.00163	CcSEcCtD
Dactinomycin—Nausea—Methylprednisolone—psoriatic arthritis	0.000349	0.00163	CcSEcCtD
Dactinomycin—Hypersensitivity—Prednisone—psoriatic arthritis	0.000342	0.0016	CcSEcCtD
Dactinomycin—Vomiting—Betamethasone—psoriatic arthritis	0.000339	0.00158	CcSEcCtD
Dactinomycin—Vomiting—Dexamethasone—psoriatic arthritis	0.000339	0.00158	CcSEcCtD
Dactinomycin—Decreased appetite—Methotrexate—psoriatic arthritis	0.000338	0.00158	CcSEcCtD
Dactinomycin—Rash—Dexamethasone—psoriatic arthritis	0.000337	0.00157	CcSEcCtD
Dactinomycin—Rash—Betamethasone—psoriatic arthritis	0.000337	0.00157	CcSEcCtD
Dactinomycin—Fatigue—Methotrexate—psoriatic arthritis	0.000335	0.00156	CcSEcCtD
Dactinomycin—Asthenia—Prednisone—psoriatic arthritis	0.000334	0.00156	CcSEcCtD
Dactinomycin—Pain—Methotrexate—psoriatic arthritis	0.000332	0.00155	CcSEcCtD
Dactinomycin—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00032	0.00149	CcSEcCtD
Dactinomycin—Diarrhoea—Prednisone—psoriatic arthritis	0.000318	0.00149	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000318	0.00148	CcSEcCtD
Dactinomycin—Nausea—Dexamethasone—psoriatic arthritis	0.000317	0.00148	CcSEcCtD
Dactinomycin—Nausea—Betamethasone—psoriatic arthritis	0.000317	0.00148	CcSEcCtD
Dactinomycin—Abdominal pain—Methotrexate—psoriatic arthritis	0.000307	0.00143	CcSEcCtD
Dactinomycin—Body temperature increased—Methotrexate—psoriatic arthritis	0.000307	0.00143	CcSEcCtD
Dactinomycin—Vomiting—Prednisone—psoriatic arthritis	0.000296	0.00138	CcSEcCtD
Dactinomycin—Rash—Prednisone—psoriatic arthritis	0.000293	0.00137	CcSEcCtD
Dactinomycin—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000286	0.00134	CcSEcCtD
Dactinomycin—Asthenia—Methotrexate—psoriatic arthritis	0.000279	0.0013	CcSEcCtD
Dactinomycin—Nausea—Prednisone—psoriatic arthritis	0.000276	0.00129	CcSEcCtD
Dactinomycin—Diarrhoea—Methotrexate—psoriatic arthritis	0.000266	0.00124	CcSEcCtD
Dactinomycin—Vomiting—Methotrexate—psoriatic arthritis	0.000247	0.00115	CcSEcCtD
Dactinomycin—Rash—Methotrexate—psoriatic arthritis	0.000245	0.00114	CcSEcCtD
Dactinomycin—Nausea—Methotrexate—psoriatic arthritis	0.000231	0.00108	CcSEcCtD
